Hongqun Liu

2.4k total citations
68 papers, 1.7k citations indexed

About

Hongqun Liu is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Hongqun Liu has authored 68 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Hepatology, 23 papers in Epidemiology and 19 papers in Surgery. Recurrent topics in Hongqun Liu's work include Liver Disease and Transplantation (35 papers), Liver Disease Diagnosis and Treatment (22 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (7 papers). Hongqun Liu is often cited by papers focused on Liver Disease and Transplantation (35 papers), Liver Disease Diagnosis and Treatment (22 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (7 papers). Hongqun Liu collaborates with scholars based in Canada, China and South Korea. Hongqun Liu's co-authors include Samuel S. Lee, Samuel Lee, Daisheng Song, Z Ma, Seyed Ali Gaskari, Ki Tae Yoon, Leila Moezi, Soon Koo Baik, Mouhieddin Traboulsi and Saumya Jayakumar and has published in prestigious journals such as Gastroenterology, Hepatology and Gut.

In The Last Decade

Hongqun Liu

62 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongqun Liu Canada 25 1.0k 775 490 339 270 68 1.7k
Manabu Hayashi Japan 23 250 0.2× 380 0.5× 205 0.4× 281 0.8× 463 1.7× 109 1.6k
Hajime Maeta Japan 25 514 0.5× 407 0.5× 652 1.3× 258 0.8× 319 1.2× 98 1.8k
Christian Eipel Germany 21 702 0.7× 526 0.7× 630 1.3× 51 0.2× 239 0.9× 41 1.4k
L Hernando Spain 26 302 0.3× 229 0.3× 204 0.4× 206 0.6× 239 0.9× 96 1.7k
Josef Wanninger Germany 22 158 0.2× 1.1k 1.5× 229 0.5× 278 0.8× 480 1.8× 36 1.8k
Vanessa Lavallard Switzerland 19 116 0.1× 595 0.8× 599 1.2× 76 0.2× 610 2.3× 39 1.7k
R. Leiderer Germany 18 351 0.3× 195 0.3× 801 1.6× 36 0.1× 222 0.8× 31 1.3k
Wei Qu China 19 248 0.2× 202 0.3× 393 0.8× 107 0.3× 315 1.2× 115 1.3k
Nicolas Veyrie France 21 311 0.3× 1.2k 1.6× 912 1.9× 404 1.2× 551 2.0× 44 2.9k
Geurt Stokman Netherlands 17 128 0.1× 209 0.3× 270 0.6× 76 0.2× 528 2.0× 30 1.4k

Countries citing papers authored by Hongqun Liu

Since Specialization
Citations

This map shows the geographic impact of Hongqun Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongqun Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongqun Liu more than expected).

Fields of papers citing papers by Hongqun Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongqun Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongqun Liu. The network helps show where Hongqun Liu may publish in the future.

Co-authorship network of co-authors of Hongqun Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Hongqun Liu. A scholar is included among the top collaborators of Hongqun Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongqun Liu. Hongqun Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kumar, Hitendra, Hongqun Liu, Giovanniantonio Natale, et al.. (2025). Bioprinting of hepatic tissue model using photocrosslinkable dECM-containing composite hydrogel. Materials Today Bio. 32. 101824–101824. 1 indexed citations
2.
Yoon, Ki Tae, et al.. (2024). The Cardiomyocyte in Cirrhosis: Pathogenic Mechanisms Underlying Cirrhotic Cardiomyopathy. Reviews in Cardiovascular Medicine. 25(12). 457–457. 2 indexed citations
3.
Liu, Hongqun, et al.. (2024). Therapies for Cirrhotic Cardiomyopathy: Current Perspectives and Future Possibilities. International Journal of Molecular Sciences. 25(11). 5849–5849. 2 indexed citations
4.
Liu, Hongqun, Jwan A. Naser, Grace Lin, & Samuel S. Lee. (2024). Reply to: Correspondence on “Cardiomyopathy in cirrhosis: From pathophysiology to clinical care”. JHEP Reports. 6(9). 101129–101129.
5.
Ryu, Dae Gon, et al.. (2024). Clinical outcomes of esophageal squamous cell carcinoma in patients with cirrhosis. Clinical and Translational Radiation Oncology. 48. 100817–100817.
6.
Kumar, Hitendra, et al.. (2023). Recent Advances in Organ‐on‐Chips Integrated with Bioprinting Technologies for Drug Screening. Advanced Healthcare Materials. 12(20). e2203172–e2203172. 40 indexed citations
7.
Liu, Hongqun, Henry H. Nguyen, Sang Youn Hwang, & Samuel S. Lee. (2023). Oxidative Mechanisms and Cardiovascular Abnormalities of Cirrhosis and Portal Hypertension. International Journal of Molecular Sciences. 24(23). 16805–16805. 7 indexed citations
8.
Hwang, Sang Youn, Hongqun Liu, & Samuel S. Lee. (2023). Dysregulated Calcium Handling in Cirrhotic Cardiomyopathy. Biomedicines. 11(7). 1895–1895. 1 indexed citations
9.
El‐Kassas, Mohamed, Mohamed Hassany, Gamal Esmat, et al.. (2023). A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C. Journal of Hepatology. 79(2). 314–320. 9 indexed citations
10.
Liu, Hongqun, Daljeet Chahal, Vladimir Marquez, & Samuel S. Lee. (2023). Cirrhotic cardiomyopathy. Elsevier eBooks. 85(9). 217–246. 1 indexed citations
11.
Liu, Hongqun, et al.. (2023). Oxidative stress triggers hyperdynamic circulation via central neural activation in portal hypertensive rats. Hepatology International. 17(3). 689–697. 3 indexed citations
12.
Liu, Hongqun, Sang Youn Hwang, & Samuel S. Lee. (2023). Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy. Pharmaceuticals. 16(7). 978–978. 7 indexed citations
13.
Liu, Hongqun, Jwan A. Naser, Grace Lin, & Samuel S. Lee. (2023). Cardiomyopathy in cirrhosis: From pathophysiology to clinical care. JHEP Reports. 6(1). 100911–100911. 28 indexed citations
14.
15.
Yoon, Ki Tae, et al.. (2022). Galectin-3 inhibits cardiac contractility via a tumor necrosis factor alpha-dependent mechanism in cirrhotic rats. Clinical and Molecular Hepatology. 28(2). 232–241. 9 indexed citations
16.
Vandenberk, Bert, Mario Altieri, Hongqun Liu, Satish R. Raj, & Samuel S. Lee. (2022). Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension. Alimentary Pharmacology & Therapeutics. 57(3). 290–303. 9 indexed citations
17.
Chahal, Daljeet, et al.. (2021). Review article: comprehensive analysis of cirrhotic cardiomyopathy. Alimentary Pharmacology & Therapeutics. 53(9). 985–998. 31 indexed citations
18.
Yoon, Ki Tae, Hongqun Liu, & Samuel S. Lee. (2020). Cirrhotic Cardiomyopathy. Current Gastroenterology Reports. 22(9). 43 indexed citations
19.
Honar, Hooman, et al.. (2020). Impaired myosin isoform shift and calcium transients contribute to cellular pathogenesis of rat cirrhotic cardiomyopathy. Liver International. 40(11). 2808–2819. 18 indexed citations
20.
Liu, Hongqun & Samuel S. Lee. (2008). Nuclear factor‐κB inhibition improves myocardial contractility in rats with cirrhotic cardiomyopathy. Liver International. 28(5). 640–648. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manabu Hayashi Breakdown of academic impact, for papers by Hajime Maeta Breakdown of academic impact, for papers by Christian Eipel Breakdown of academic impact, for papers by L Hernando Breakdown of academic impact, for papers by Josef Wanninger Breakdown of academic impact, for papers by Vanessa Lavallard Breakdown of academic impact, for papers by R. Leiderer Breakdown of academic impact, for papers by Wei Qu Breakdown of academic impact, for papers by Nicolas Veyrie Breakdown of academic impact, for papers by Geurt Stokman
Rankless by CCL
2026